Statins may reduce risk of Alzheimer's diseaseBMJ 2000; 321 doi: https://doi.org/10.1136/bmj.321.7268.1040 (Published 28 October 2000) Cite this as: BMJ 2000;321:1040
- Deborah Josefson
- San Francisco
Patients taking the statin class of cholesterol lowering drugs may derive the extra benefit of a reduction in risk of Alzheimer's disease, according to a new study (Archives of Neurology 2000;57:1439-43).
As high levels of cholesterol have been associated with Alzheimer's disease, and a cholesterol transport isoprotein, apolipoprotein E4, is known to increase the risk of the disease, the study authors set out to determine if statins could reduce the incidence of Alzheimer's disease.
Led by Dr Benjamin Wolozin of Loyola University Medical Center in Maywood, Illinois, and Paul Rousseau of the Carl T Hayden Veteran …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial